Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Gregory

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Sensors (Basel, Switzerland)|March 10, 2015
Distributed efficient similarity search mechanism in wireless sensor networksKhandakar Ahmed, Mark A Gregory
The Journal of Biological Chemistry|October 18, 2003
Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localizationMark A Gregory, Ying Qi, Stephen R Hann
Immunologic Research|September 4, 2012
Using functional genomics to overcome therapeutic resistance in hematological malignanciesFrancesca Alvarez-Calderon, Mark A Gregory, James DeGregori
Cell Cycle (Georgetown, Tex.)|January 19, 2005
The ARF tumor suppressor: keeping Myc on a leashMark A Gregory, Ying Qi, Stephen R Hann
Oncogene|July 9, 2004
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxolAaron M Domina, Julie A Vrana, Mark A Gregory, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2013
Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activityQin Zhang, Erick Spears, David N Boone, et al.
Nature|September 14, 2004
p19ARF directly and differentially controls the functions of c-Myc independently of p53Ying Qi, Mark A Gregory, Zhaoliang Li, et al.
Experimental Hematology|September 27, 2017
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemiaMark A Gregory, Travis Nemkov, Julie A Reisz, et al.
Elife|October 19, 2022
Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylationHae J Park, Mark A Gregory, Vadym Zaberezhnyy, et al.
Plos One|October 12, 2012
Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancerShanna K Nifoussi, Julie A Vrana, Aaron M Domina, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|March 10, 2015
Distributed efficient similarity search mechanism in wireless sensor networksKhandakar Ahmed, Mark A Gregory
The Journal of Biological Chemistry|October 18, 2003
Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localizationMark A Gregory, Ying Qi, Stephen R Hann
Immunologic Research|September 4, 2012
Using functional genomics to overcome therapeutic resistance in hematological malignanciesFrancesca Alvarez-Calderon, Mark A Gregory, James DeGregori
Cell Cycle (Georgetown, Tex.)|January 19, 2005
The ARF tumor suppressor: keeping Myc on a leashMark A Gregory, Ying Qi, Stephen R Hann
Oncogene|July 9, 2004
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxolAaron M Domina, Julie A Vrana, Mark A Gregory, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2013
Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activityQin Zhang, Erick Spears, David N Boone, et al.
Nature|September 14, 2004
p19ARF directly and differentially controls the functions of c-Myc independently of p53Ying Qi, Mark A Gregory, Zhaoliang Li, et al.
Experimental Hematology|September 27, 2017
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemiaMark A Gregory, Travis Nemkov, Julie A Reisz, et al.
Elife|October 19, 2022
Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylationHae J Park, Mark A Gregory, Vadym Zaberezhnyy, et al.
Plos One|October 12, 2012
Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancerShanna K Nifoussi, Julie A Vrana, Aaron M Domina, et al.
Pageof 2